New pharmacology updates
- Alirocumab is recently approved for treatment of
A. Heterozygous familial hypercholesterolemia
B. Homozygous familial hypertriglyceridemia
C. Homozygous familial hypercholesterolemia
D. Heterozygous familial hypertriglyceridemia